secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001829126-26-003301
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZEO signs MOU to be exclusive biologics supplier for Regen Therapy's 3,000-clinic network
--------------------------------------------------------------------------------

- MOU positions ZEO as core supplier of advanced biologic therapeutics for Regen Therapy's regenerative platform.
- Regen Therapy's network includes over 3,000 clinics and 24,000 practitioners across the U.S.
- Regen also partnered with Stealth Health for white-label telemedicine and longevity services.
- No financial terms or binding agreement disclosed; MOU is non-definitive.
- ZEO's expertise in extracellular vesicle and perinatal-derived therapeutics to support next-gen products.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912626003301/0001829126-26-003301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912626003301/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-003301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer